ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 173 filers reported holding ANI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $686,000 | -11.4% | 9,412 | 0.0% | 0.80% | -12.1% |
| Q2 2019 | $774,000 | +16.6% | 9,412 | 0.0% | 0.91% | +15.9% |
| Q1 2019 | $664,000 | +45.0% | 9,412 | -7.5% | 0.78% | +18.8% |
| Q4 2018 | $458,000 | -14.7% | 10,180 | +7.1% | 0.66% | +4.9% |
| Q3 2018 | $537,000 | +23.4% | 9,503 | +45.9% | 0.63% | +44.8% |
| Q2 2018 | $435,000 | -20.5% | 6,514 | -30.6% | 0.43% | 0.0% |
| Q1 2018 | $547,000 | -12.3% | 9,387 | -3.1% | 0.43% | +0.7% |
| Q4 2017 | $624,000 | +42.8% | 9,686 | +16.4% | 0.43% | +34.0% |
| Q3 2017 | $437,000 | +84.4% | 8,319 | +64.0% | 0.32% | +66.3% |
| Q2 2017 | $237,000 | -5.6% | 5,073 | 0.0% | 0.19% | -7.7% |
| Q1 2017 | $251,000 | +2.4% | 5,073 | +15.7% | 0.21% | -10.7% |
| Q2 2016 | $245,000 | +18.9% | 4,383 | -4.2% | 0.23% | +14.7% |
| Q4 2015 | $206,000 | – | 4,574 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |